The Role of Carnitine and Carnitine Supplementation During Exercise in Man and in Individuals with Special Needs

REFERENCES

• Holloszy JO, Coyle EF: Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 56: 831–838, 1984.
   PubMed Web of Science ®Google Scholar
• Berthon P, Freyssenet D, Chatard J-C, Castells J, Mujika I, Geyssant A, Guezennec C-Y, Denis C: Mitochondrial ATP production rate in 55 to 73-year-old-men: effect of endurance training. Acta Physiol Scand 154: 269–274, 1995.
   PubMedGoogle Scholar
• Elliott DL, Buist NRM, Goldberg L, Kennaway NG, Powell BR, Kuehl MS: Metabolic myopathies: evaluation by graded exercise testing. Medicine 68: 163–172, 1989.
   PubMed Web of Science ®Google Scholar
• Bremer J: Carnitine—metabolism and functions. Physiol Rev 63: 1420–1480, 1983.
   PubMed Web of Science ®Google Scholar
• Wasserman K, Whipp BJ: Exercise physiology in health and disease. Am Rev Resp Dis 112: 219–249, 1975.
   PubMed Web of Science ®Google Scholar
• Brass EP: Overview of coenzyme A metabolism and its role in cellular toxicity. Chem-Biol Interact 90: 203–214, 1994.
   PubMed Web of Science ®Google Scholar
• Gilbert EF: Carnitine deficiency. Pathol 17: 161–169, 1985.
   PubMed Web of Science ®Google Scholar
• Hiatt WR, Wolfel EE, Regensteiner JG, Ruff L, Brass EP: Carnitine metabolism during exercise in humans: dependence on skeletal muscle metabolic state. J Clin Invest 84: 1167–1173, 1989.
   PubMed Web of Science ®Google Scholar
• Sahlin K: Muscle carnitine metabolism during incremental dynamic exercise in humans. Acta Physiol Scand 138: 259–262, 1990.
   PubMedGoogle Scholar
• Minkler PE, Brass EP, Hiatt WR, Ingalls ST, Hoppel CL: Quantification of carnitine, acetylcarnitine and total carnitine in tissues by high-performance liquid chromatography: the effect of exercise on carnitine homeostasis in man. Analyt Biochem 231: 315–322, 1995.
   PubMed Web of Science ®Google Scholar
• Constantin-Teodosiu D, Carlin JI, Cederblad G, Harris RC, Hultman E: Acetyl group accumulation and pyruvate dehydrogenase activity in human muscle during incremental exercise. Acta Physiol Scand 143: 367–372, 1991.
   PubMedGoogle Scholar
• Bremer J: The role of carnitine in intracellular metabolism. J Clin Chem Biochem 28: 297–301, 1990.
   PubMedGoogle Scholar
• Goa KL, Brogden RN: L-Carnitine. Drugs 34: 1–24, 1987.
   Web of Science ®Google Scholar
• Brass EP: Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients. Clin Ther 17: 176–185, 1995.
   PubMedGoogle Scholar
• Cerretelli P, Marconi C: L-Carnitine supplementation in humans. The effects on physical performance. Int J Sports Med 11: 1–14, 1990.
   PubMed Web of Science ®Google Scholar
• Brass EP, Hiatt WR: Carnitine metabolism during exercise. Life Sci 54: 1383–1393, 1994.
   PubMed Web of Science ®Google Scholar
• Brass EP: Supplemental carnitine and exercise. Am J Clin Nutr (in press)
   Google Scholar
• Costill DL, Coyle E, Dalsky G, Evans W, Fink W, Hoopes D: Effects of elevated plasma FFA and insulin on muscle glycogen usage during exercise. J Appl Physiol 43: 395–699, 1977.
   Google Scholar
• Green HJ: How important is endogenous muscle glycogen to fatigue in prolonged exercise? Can J Physiol Pharmacol 69: 290–297, 1991.
   PubMedGoogle Scholar
• Livesey G, Elia M: Estimation of energy expenditure, net carbohydrate utilization and net fat oxidation and synthesis by indirect calorimetry: evaluation of errors with special reference to the detailed consumption of fuels. Am J Clin Nutr 47: 608–628, 1988.
   PubMed Web of Science ®Google Scholar
• Marconi C, Sassi G, Carpinelli A, Cerretelli P: Effects of L-carnitine loading on the aerobic and anaerobic performance of endurance athletes. Eur J Appl Physiol 54: 131–135, 1985.
   PubMed Web of Science ®Google Scholar
• Otto RM, Shores KVM, Wygand JW, Perez MR: The effect of L-carnitine supplementation on endurance exercise. Med Sci Sports Exer 19: S68, 1987.
   Google Scholar
• Oyono-Enguelle S, Freund H, Ott C, Gartner M, Heitz A, Marbach J, Maccari F, Grey A, Bigot M, Bach AC: Prolonged submaximal exercise and L-carnitine in humans. Eur J Appl Physiol 58: 53–61, 1988.
   Google Scholar
• Soop M, Bjorkman O, Cederblad G, Hegenfeldt L, Wahren J: Influence of carnitine supplementation on muscle substrate and carnitine metabolism during exercise. J Appl Physiol 64: 2394–2399, 1988.
   PubMed Web of Science ®Google Scholar
• Decombaz J, Deriaz O, Acheson K, Giavemder B, Jeguier E: Effect of L-carnitine on submaximal exercise metabolism after depletion of muscle glycogen. Med Sci Sports Exerc 25: 733–7410, 1993.
   PubMed Web of Science ®Google Scholar
• Brass EP, Hoppel CL, Hiatt WR: Effect of intravenous L-carnitine on carnitine homeostasis and fuel metabolism during exercise in humans. Clin Pharmacol Ther 55: 681–692, 1994.
   PubMed Web of Science ®Google Scholar
• Vukovich MD, Costill DL, Fink WJ: Carnitine supplementation: effect on muscle carnitine and glycogen content during exercise. Med Sci Sports Exerc 26: 1122–1129, 1994.
   PubMed Web of Science ®Google Scholar
• Gorostiaga EM, Maurer CA, Eclache JP: Decreases in respiratory quotient during exercise following L-carnitine supplementation. Int J Sports Med 10: 169–174, 1989.
   PubMed Web of Science ®Google Scholar
• Decombaz JE, Roffet B, Bloemhard Y: L-carnitine supplementation, caffeine and fuel oxidation in the exercising rat. Nutr Res 7: 923–933, 1987.
   Google Scholar
• Decombaz JE, Roffet B, Bloemhard Y: Effect of L-carnitine and stimulated lipolysis on muscle substrates in the exercising rat. Experientia 46: 457–458, 1990.
   PubMedGoogle Scholar
• Simi B, Mayet MH, Sempure B, Favier RJ: Large variations in skeletal muscle carnitine level fail to modify energy metabolism in exercising rate. Comp Biochem Physiol 97A: 543–549, 1990.
   Google Scholar
• Lysiak W, Lilly K, DiLisa F, Toth PP, Bieber LL: Quantitation of the effect of L-carnitine on the levels of acid-soluble short-chain acyl-CoA and CoASH in rat heart and liver mitochondria. J Biol Chem 263: 1151–1156, 1988.
   PubMed Web of Science ®Google Scholar
• Uziel G, Garavaglia B, DiDonato S: Carnitine stimulation of pyruvate dehydrogenase complex (PDHC) in isolated human skeletal muscle mitochondria. Muscle Nerve 11: 720–724, 1988.
   PubMed Web of Science ®Google Scholar
• Brass EP, Hoppel CL: Effect of carnitine on mitochondrial oxidation of palmitoylcarnitine. Biochem J 188: 451–458, 1980.
   PubMedGoogle Scholar
• Brass EP, Hoppel CL: Relationship between acid-soluble carnitine and coenzyme A pools in vivo. Biochem J 190: 495–504, 1980.
   PubMed Web of Science ®Google Scholar
• Putman CT, Spriet LL, Hultman E, Dyek DJ, Heigenhauser GJF: Skeletal muscle pyruvate dehydrogenase activity during acetate infusion in humans. Am J Physiol 268: E1007–E1017, 1995.
   Google Scholar
• Bremer J: Pyruvate dehydrogenase, substrate specificity and product inhibition. Eur J Biochem 8: 535–540, 1969.
   PubMedGoogle Scholar
• Davis JM: Central and peripheral factors in fatigue. J Sports Sci 13: 549–554, 1995.
   Google Scholar
• Miller RG, Kent-Braun JA, Sharma KR, Weiner MW: Mechanisms of human muscle fatigue. Quantitating the contribution of metabolic factors and activation impairment. Adv Exp Med Biol 384: 195–210, 1995.
   PubMedGoogle Scholar
• Dubelaar M-L, Lucas CMHB, Hulsmann WC: Acute effect of L-carnitine on skeletal muscle force tests in dogs. Am J Physiol 260: E189–E193, 1993.
   Google Scholar
• Brass EP, Scarrow AM, Ruff LJ, Masterson K, van Lunteren E: Carnitine delays rat skeletal muscle fatigue in vitro. J Appl Physiol 75: 1959–1600, 1993.
   Google Scholar
• Dubelaar M-L, Lucas CMBH, Hulsmann WC: The effect of L-carnitine on force development of the latissimus dorsi muscle in dogs. J Cardiac Surg 6(Suppl): 270–275, 1991.
   Google Scholar
• Cevese A, Schena F, Poltronieri R, Cerutti G: Short term effects of intra-arterial propionyl-L-carnitine on isolated canine hind-limbs. Cardioscience 6: 59–64, 1995.
   PubMedGoogle Scholar
• Hulsmann WC, Dubelaar M-L: Carnitine requirement of vascular endothelial and smooth muscle cells in imminent ischemia. Mol Cell Biochem 116: 125–129, 1992.
   PubMedGoogle Scholar
• Harper P, Elwin C-E, Cederblad G: Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects. Eur J Clin Pharmacol 35: 69–75, 1988.
   PubMedGoogle Scholar
• Segre G, Bianchi E, Corsi M, D’Iddio S, Ghirardi O, Maccari F: Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man. Arzneim-Forsch Drug Res 11: 1830–1834, 1988.
   Google Scholar
• Millington DS, Dubag G: Dietary supplement L-carnitine: analysis of different brands to determine bioavailability and content. Clin Res Regulatory Affairs 10: 71–80, 1993.
   Google Scholar
• Greig C, Finch KM, Jones DA, Cooper M, Sargeant AJ, Forte CA: The effects of oral supplementation with L-carnitine on maximum and submaximum exercise capacity. Eur J Appl Physiol 56: 457–460, 1987.
   PubMed Web of Science ®Google Scholar
• Dragan GI, Vasiliu A, Georgeseu E, Dumas I: Studies concerning chronic and acute effects of L-carnitine on some biological parameters in elite athletes. Physiologie 24: 23–28, 1987.
   PubMedGoogle Scholar
• Vecchiet L, Di Lisa F, Pieralisi G, Ripari P, Menabo R, Giamberardino MA, Siliprandi N: Influence of L-carnitine administration on maximal physical exercise. Eur J Appl Physiol 61: 486–490, 1990.
   PubMed Web of Science ®Google Scholar
• Wyss V, Ganzit GP, Rienzi A: Effects of L-carnitine administration on VO2max and aerobic-anaerobic threshold in normoxia and acute hypoxia. Eur J Appl Physiol 60: 1–6, 1990.
   PubMed Web of Science ®Google Scholar
• Hultman E, Cederblad G, Harper P: Carnitine administration as a tool to modify energy metabolism during exercise. Eur J Appl Physiol 6: 450, 1991.
   Google Scholar
• Barnett C, Costill DL, Vukovich MD, Cole KJ, Goodpaster BH, Trappe SW, Fink WJ: Effect of L-carnitine supplementation on muscle and blood carnitine content and lactate accumulation during high-intensity sport cycling. Int J Sports Nutr 4: 280–288, 1994.
   PubMed Web of Science ®Google Scholar
• Swart I, Rossouw J, Loots JM, Kruger MC: The effect of L-carnitine supplementation on plasma carnitine levels and various performance parameters of male marathon athletes. Nutr Res 17: 405–414, 1997.
   Web of Science ®Google Scholar
• Trappe SW, Costill DL, Goodpaster B, Vukovich MD, Fink WJ: The effects of L-carnitine supplementation on performance during interval swimming. Int J Sports Med 15: 181–185, 1994.
   PubMed Web of Science ®Google Scholar
• Columbani P, Werk C, Kurz I, Krahenbuhl S, Kuhut M, Arnold M, Frey-Rindora P, Frey W, Langhans W: Effects of L-carnitine supplementation on physical performance and energy metabolism of endurance—trained athletes: A double-blind crossover field study. Eur J Appl Physiol 73: 434–439, 1996.
   PubMed Web of Science ®Google Scholar
• Arenas J, Ricoy JR, Encinas AR, Pola P, D’Iddio S, Zeviani M, Di Donato S, Corsi M: Carnitine in muscle, serum and urine of nonprofessional athletes: effect of physical exercise, training and L-carnitine administration. Muscle Nerve 14: 598–604, 1991.
   PubMed Web of Science ®Google Scholar
• Huertas R, Campos Y, Diaz E, Esteban J, Vechietti L, Montanari G, D’Iddio S, Corsi M, Arenas J: Respiratory chain enzymes in muscle of endurance athletes: effect of L-carnitine. Biochem Biophys Res Commun 188: 102–107, 1992.
   PubMed Web of Science ®Google Scholar
• Arenas J, Huertas R, Campos Y, Diaz AE, Villalon JM, Vilas E: Effects of L-carnitine on the pyruvate dehydrogenase complex and carnitine palmitoyltransferase activities of endurance athletes. FEBS Lett 341: 91–93, 1994.
   PubMed Web of Science ®Google Scholar
• Friolet R, Hoppeler H, Krahenbuhl S: Relationship between the coenzyme A pools in human skeletal muscle at rest and after exhaustive exercise under normoxic and acutely hypoxic conditions. J Clin Invest 94: 1490–1495, 1995.
   Google Scholar
• Barnea N, Drory Y, Iaina A, Lapidot C, Reisen E, Eliahou H, Kellermann JJ: Exercise tolerance in patients on chronic hemodialysis. Isr J Med Sci 16: 17–21, 1980.
   PubMedGoogle Scholar
• Ricanati ES, Tserng K, Hoppel CL: Abnormal fatty acid utilization during prolonged fasting in chronic uremia. Kidney Int 32(Suppl 22): S145–S148, 1987.
   Google Scholar
• Wanner C, Horl WH: Carnitine abnormalities in patients with renal insufficiency. Nephron 50: 89–102, 1988.
   PubMed Web of Science ®Google Scholar
• Brass EP: Carnitine in renal failure. In Kopple JD, Massry SG (eds): “Nutritional Management of Renal Disease.” Baltimore: Williams and Wilkens, pp 191–201, 1997.
   Google Scholar
• Hiatt WR, Koziol BS, Shapiro JI, Brass EP: Carnitine metabolism during exercise in patients on chronic hemodialysis. Kidney Int 41: 1613–1619, 1992.
   PubMedGoogle Scholar
• Fagher B, Cederblad G, Eriksson M, Menti M, Moritz U, Nillson-Ehle P, Thysell H: 1-Carnitine and hemodialysis: double blind study on muscle function and metabolism and peripheral nerve function. Scand J Clin Lab Invest 45: 169–178, 1985.
   PubMed Web of Science ®Google Scholar
• Golper TS, Wolfson M, Ahmad S, Hirschberg R, Kurtin P, Katz LA, Nicora R, Ashbrook D, Kopple JD: Multicenter trial of 1-Carnitine in hemodialysis patients. I. Carnitine concentrations and lipid effects. Kidney Int 38: 904–911, 1990.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Robertson T, Golper TA, Wolfson M, Kurtin P, Katz LA, Hirschberg R, Nicora R, Ashbrook DW, Kopple JD: Multicenter trial of 1-Carnitine in hemodialysis patients. II. Clinical and biochemical effects. Kidney Int 38: 912–918, 1990.
   PubMed Web of Science ®Google Scholar
• Spagnoli LG, Palmieri G, Mauriello A, Vacha GM, D’Iddio S, Giorcelli G, Corsi M: Morphometric evidence of the trophic effect of L-carnitine on human skeletal muscle. Nephron 55: 16–23, 1990.
   PubMed Web of Science ®Google Scholar
• Siami G, Clinton ME, Mrak R, Griffis J, Stone W. Evaluation of the effect of intravenous 1-carnitine therapy on function, structure and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis. Nephron 57: 306–313, 1991.
   PubMed Web of Science ®Google Scholar
• Bellinghieri G, Savica V, Mallamace A, Di Stefano C, Consolo F, Spagnoli LG, Villaschi S, Palmieri G, Corsi M, Maccari F: Correlation between increased serum and tissue l-carnitine levels and improved muscle symptoms in hemodialysis patients. Am J Clin Nutr 38: 523–531, 1983.
   PubMed Web of Science ®Google Scholar
• Janssen E, Johansson J, Sylven C, Kaijser L: Calf muscle adaptation in intermittent claudication. Side differences in muscle metabolic characteristics in patients with unilateral arterial disease. Clin Physiol 8: 17–29, 1988.
   PubMedGoogle Scholar
• Hiatt WR, Wolfel EE, Regensteiner JG, Brass EP: Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease. J Appl Physiol 73: 346–353, 1992.
   PubMed Web of Science ®Google Scholar
• Brass EP: Skeletal muscle metabolism as a target for drug therapy in peripheral arterial disease. Vasc Med 1: 55–59, 1996.
   PubMedGoogle Scholar
• Brevetti G, Chiariello M, Ferulano G, Policicchio A, Nevola E, Rossini A, Attisano T, Ambrosio G, Siliprandi N, Angelini C: Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study. Circulation 77: 767–773, 1988.
   PubMed Web of Science ®Google Scholar
• DiLisa F, Menabo R, Siliprandi N: L-Propionylcarnitine protection of mitochondria in ischemic rat hearts. Mol Cell Biochem 88: 169–173, 1989.
   PubMedGoogle Scholar
• Paulson DJ, Taxler J, Schmidt M, Noonan J, Shug AL: Protection of the ischemic myocardium by L- propionylcarnitine: effects on the recovery of cardiac output after ischemia and reperfusion, carnitine transport, and fatty acid oxidation. Cardiovasc Res 20: 536–541, 1986.
   PubMed Web of Science ®Google Scholar
• Brevetti G, Perna S, Sabba C, Martone VD, Condurelli M: Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study. J Am Coll Cardiol 26: 1411–1416, 1995.
   PubMed Web of Science ®Google Scholar
• Brevetti G, Perna S, Sabba C, Martone VD, Di Lorio A, Barletta G: Effect of Propionyl-L-carnitine on quality of life in intermittent claudication. Am J Cardiol 79: 777–780, 1997.
   PubMed Web of Science ®Google Scholar
• Hiatt WR: Current and future drug therapies for claudication. Vasc Med (in press).
   Google Scholar
• Plioplys AV, Plioplys S: Amantadine and L-carnitine treatment of chronic fatigue syndrome. Neuropsychobiology 35: 16–23, 1997.
   PubMed Web of Science ®Google Scholar
• Cherchi A, Lai C, Angelino F, Trucco G, Caponnetto S, Mereto PE, Rosolen G, Manzoli U, Schiavoni G, Reale A, Romeo F, Rizzon P, Sorgente L, Strano A, Novo S, Immordino R: Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study. Int J Clin Pharmacol Ther Toxicol 23: 569–572, 1985.
   PubMedGoogle Scholar
• Dal Negro R, Turco P, Pomari C, De Conti F: Effects of L-carnitine on physical performance in chronic respiratory insufficiency. Int J Clin Pharmacol Ther Toxicol 26: 269–272, 1988.
   PubMedGoogle Scholar